Abstract:Poly(L-glutamic acid) (PLG) and its derivatives, which are biodegradable and biocompatible, are one kind of the most widely investigated synthetic polypeptides as biomedical materials benefited from their pH-responsive property (pK(a) similar to 4.1) and modifiable side carboxyl group. In this work, PLG was synthesized via a two-step procedure. Poly(gamma-benzyl-L-glutamate) (PBLG) was first synthesized by the ring-opening polymerization of gamma-benzyl-L-glutamate-N-carboxyanhydride (BLG-NCA) using n-hexylamine as initiator, and then PLG was prepared by the deprotection of benzyl groups in PBLG. PLG microsphere was prepared by the oil-in-oil (O/O) anhydrous emulsion method utilizing N, N-dimetylformamide as an inner oil phase and corn oil as an outer oil phase. Rifampicin, a model drug, was loaded into the PLG microsphere, and the drug loading capacity and entrapment efficiency were revealed. The scanning electron microscopy micrograph indicated that the drug-loaded microsphere exhibited spherical morphology with narrow size distribution and average diameter at about 9.0 mu m. To investigate the application of PLG microsphere in oral drug delivery (especially for enteric-coated drugs), the in vitro rifampicin release experiments in simulated gastric or intestinal fluid were performed. In vitro release results revealed that the release of rifampicin from microsphere was highly dependent on pH. In detail, less amount of rifampicin was released in simulated gastric fluid, while the quicker release of rifampicin occurred in simulated intestinal fluid. It was because that the deprotonation of carboxyl groups in PLG caused the loose, expansion, and even disintegration of PLG microsphere in simulated intestinal fluid. Moreover, the morphology of microsphere in simulated gastric fluid was different from that in simulated intestinal fluid, which further confirmed the pH-sensitive property of microsphere. Additionally, in vitro methyl thiazolyl tetrazolium assays demonstrated that the PLG microsphere was biocompatible. Therefore, the biocompatible PLG microsphere with the intelligent pH-triggered drug release should be promising for application in oral drug delivery.

Fabrication of Nonporous and Porous Cationic Plga Microspheres

Decoration and Application of PLGA Microspheres

Facile Fabrication of Macroporous PLGA Microspheres Via Double‐Pickering Emulsion Templates

Preparation of Poly(lactic-co-glycolic acid) Drug-Loaded Porous Solid Microspheres by Shear of Coagulation Bath Method

Microfluidic fabrication of porous PLGA microspheres without pre-emulsification step

Facile Preparation of PLGA Microspheres with Diverse Internal Structures by Modified Double‐emulsion Method for Controlled Release

Formulation of Porous Poly(lactic-Co-glycolic Acid) Microparticles by Electrospray Deposition Method for Controlled Drug Release

Novel Preparation Method for Sustained-Release Plga Microspheres Using Water-In-Oil-In-Hydrophilic-Oil-In-Water Emulsion

A method to prepare PLGA sustained-release microspheres

PLGA Microspheres Prepared Via Aqueous-aqueous Emulsification for Pulsed Drug Delivery

A Detailed View of PLGA-mPEG Microsphere Formation by Double Emulsion Solvent Evaporation Method

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

Research Progress on the Application of Porous PLGA Microspheres

Facile Fabrication of Biocompatible PLGA Drug-Carrying Microspheres by O/W Pickering Emulsions.

Poly(L-glutamic Acid) Microsphere: Preparation and Application in Oral Drug Controlled Release

Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-α,β-[N-(2-hydroxyethyl)-l-aspartamide]-g-poly(l-lactide) graft copolymers

Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) graft copolymers.

Microfluidic-Based Preparation of Plga Microspheres Facilitating Peptide Sustained-Release

Drug-nanoencapsulated PLGA Microspheres Prepared by Emulsion Electrospray with Controlled Release Behavior

Preparation of Porous Polylactide Microspheres by Emulsion‐solvent Evaporation Based on Solution Induced Phase Separation

Fabrication of Hollow Porous PLGA Microspheres for Controlled Protein Release and Promotion of Cell Compatibility